Emily Baker on Muck Rack

Emily Baker

As seen in: Mountain Advocate, MSN, The New York Times, Nature, Wiley Online Library, Memory Studies, Metro (UK), JAMA (The Journal of the American Medical Association), Metacritic, The Herald Sun, Radio New Zealand (RNZ) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Emily

Contact Emily, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A Regional Model Comparison between MODPATH and MT3D of Groundwater Travel Time Distributions

|
By Emily Baker, Paul F. Juckem, Daniel T. Feinstein, David Hart
| Wiley Online Library Verified
Introduction Estimating the travel time of groundwater and associated contaminants through an aquifer to discharge features is an important objective of many groundwater modeling studies. Groundwater travel time distributions (TTDs), which show the age distribution of groundwater discharging from the aquifer, are helpful for visualizing ranges in travel times since they are more informative than simple metrics, such as the mean age.
Open in Who Shared Issue with article?

The best TV series on Prime, Netflix and Disney+ in December

|
By Emily Baker
| MSN Verified
Continue reading More for You
Open in Who Shared View Duplicates (517) Issue with article?

Cystic fibrosis sputum media induces an overall loss of antibiotic susceptibility in Mycobacterium abscessus - npj Antimicrobials and Resistance

|
By Emily Baker
| Nature Verified
Abstract Mycobacterium abscessus complex (MABSC) comprises a group of environmental microorganisms, which are a concerning cause of opportunistic respiratory infections in patients with cystic fibrosis or bronchiectasis. Only 45.6% of MABSC treatments are successful, and therefore this is a need to discover new antimicrobials that can treat these pathogens.
Open in Who Shared Issue with article?
See all 170 licensed articles (202 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified